ArticleClinical cancer research : an official journal of the American Association for Cancer Research2018

Combined HDAC and Bromodomain Protein Inhibition Reprograms Tumor Cell Metabolism and Elicits Synthetic Lethality in Glioblastoma.

Yiru Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.